Literature DB >> 24840182

Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4.

Lin Deng1, Yulong Shang2, Shikong Guo3, Changhao Liu2, Lin Zhou2, Yi Sun2, Yongzhan Nie2, Daiming Fan2, Yuanyuan Lu2, Xuegang Guo2.   

Abstract

Ran, a member of the RasGTPase family, has been showed to function in diverse cellular processes of cancer. In the present study, we examined the effects of Ran on the cell motility in pancreatic cancer cells and explored the possible mechanism of Ran's function in the metastasis of pancreatic cancer. We demonstrated that the expression of Ran was remarkably higher in lymph lode metastases than in primary pancreatic cancer tissues. In the functional studies, stable knockdown of Ran by shRNA could efficiently inhibit the migration and invasion of pancreatic cancer cells both in vitro and in vivo. By PCR array, we analyzed the differences in the expression levels of metastasis-associated genes before and after the downregulation of Ran, and it was showed that the regulation of pancreatic cancer metastasis by Ran was partially mediated by AR and CXCR4. We further confirmed that AR and CXCR4 were significantly decreased following knockdown of Ran. These data indicated that Ran could regulate the invasion and metastasis of pancreatic cancer cells through AR and CXCR4.

Entities:  

Keywords:  AR; CXCR4; PCR array; Ran; invasion; metastasis; pancreatic cancer

Mesh:

Substances:

Year:  2014        PMID: 24840182      PMCID: PMC4119076          DOI: 10.4161/cbt.29217

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  27 in total

Review 1.  Running on Ran: nuclear transport and the mitotic spindle.

Authors:  M Dasso
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

2.  Apoptotic histone modification inhibits nuclear transport by regulating RCC1.

Authors:  Chi-Hang Wong; Hei Chan; Chin-Yee Ho; Soak-Kuan Lai; Kheng-Sze Chan; Cheng-Gee Koh; Hoi-Yeung Li
Journal:  Nat Cell Biol       Date:  2008-12-07       Impact factor: 28.824

3.  Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins.

Authors:  Lin Deng; Yuanyuan Lu; Xiaodi Zhao; Yi Sun; Yongquan Shi; Hongwei Fan; Changhao Liu; Jinfeng Zhou; Yongzhan Nie; Kaichun Wu; Daiming Fan; Xuegang Guo
Journal:  Biochem Biophys Res Commun       Date:  2013-09-25       Impact factor: 3.575

4.  Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.

Authors:  J P Neoptolemos; J A Dunn; D D Stocken; J Almond; K Link; H Beger; C Bassi; M Falconi; P Pederzoli; C Dervenis; L Fernandez-Cruz; F Lacaine; A Pap; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

5.  Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer.

Authors:  Kohichiroh Okitsu; Tatsuo Kanda; Fumio Imazeki; Yutaka Yonemitsu; Ratna B Ray; Chawnshang Chang; Osamu Yokosuka
Journal:  Genes Cancer       Date:  2010-08

Review 6.  The Ran GTPase: theme and variations.

Authors:  Mary Dasso
Journal:  Curr Biol       Date:  2002-07-23       Impact factor: 10.834

Review 7.  The significance of cancer cell expression of the chemokine receptor CXCR4.

Authors:  Fran Balkwill
Journal:  Semin Cancer Biol       Date:  2004-06       Impact factor: 15.707

Review 8.  Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway.

Authors:  B Mellado; J Codony; M J Ribal; L Visa; P Gascón
Journal:  Clin Transl Oncol       Date:  2009-01       Impact factor: 3.405

9.  High Ran level is correlated with poor prognosis in patients with colorectal cancer.

Authors:  Hongwei Fan; Yuanyuan Lu; Hai Qin; Yi Zhou; Yong Gu; Jinfeng Zhou; Xin Wang; Daiming Fan
Journal:  Int J Clin Oncol       Date:  2012-09-06       Impact factor: 3.402

10.  Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.

Authors:  Kouji Izumi; Lei-Ya Fang; Atsushi Mizokami; Mikio Namiki; Lei Li; Wen-Jye Lin; Chawnshang Chang
Journal:  EMBO Mol Med       Date:  2013-08-27       Impact factor: 12.137

View more
  13 in total

1.  Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer.

Authors:  Jianbo Zhang; Chengxin Liu; Xinkai Mo; Huan Shi; Sheng Li
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

2.  Ran signaling in melanoma: implications for the development of alternative therapeutic strategies.

Authors:  Emilia Caputo; Ena Wang; Anna Valentino; Stefania Crispi; Valeria De Giorgi; Annalisa Fico; Bartolomea Ficili; Mariaelena Capone; AnnaMaria Anniciello; Ernesta Cavalcanti; Gerardo Botti; Nicola Mozzillo; Paolo A Ascierto; Francesco M Marincola; Salvatore Travali
Journal:  Cancer Lett       Date:  2014-11-20       Impact factor: 8.679

Review 3.  Systems Oncology: Bridging Pancreatic and Castrate Resistant Prostate Cancer.

Authors:  A Fucic; A Aghajanyan; Z Culig; N Le Novere
Journal:  Pathol Oncol Res       Date:  2018-09-16       Impact factor: 3.201

Review 4.  Ran GTPase: A Key Player in Tumor Progression and Metastasis.

Authors:  Zied Boudhraa; Euridice Carmona; Diane Provencher; Anne-Marie Mes-Masson
Journal:  Front Cell Dev Biol       Date:  2020-05-26

5.  Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion.

Authors:  Kossay Zaoui; Zied Boudhraa; Paul Khalifé; Euridice Carmona; Diane Provencher; Anne-Marie Mes-Masson
Journal:  Nat Commun       Date:  2019-06-17       Impact factor: 14.919

6.  RETRACTED: HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells.

Authors:  Lili Yao; Yadi Zhou; Zhenhua Sui; Yanling Zhang; Yankun Liu; Hong Xie; Huijie Gao; Hongxia Fan; Yi Zhang; Min Liu; Shengping Li; Hua Tang
Journal:  EBioMedicine       Date:  2019-09-14       Impact factor: 8.143

7.  GEF-independent Ran activation shifts a fraction of the protein to the cytoplasm and promotes cell proliferation.

Authors:  Jinhan Zhou; Yuping Tan; Yuqing Zhang; Aiping Tong; Xiaofei Shen; Xiaodong Sun; Da Jia; Qingxiang Sun
Journal:  Mol Biomed       Date:  2020-12-30

8.  Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells.

Authors:  Chenyi Sheng; Jian Qiu; Yingying Wang; Zhixian He; Hua Wang; Qingqing Wang; Yeqing Huang; Lianxin Zhu; Feng Shi; Yingying Chen; Shiyao Xiong; Zhen Xu; Qichao Ni
Journal:  Mol Med Rep       Date:  2018-05-03       Impact factor: 2.952

9.  Lin28A Regulates Stem-like Properties of Ovarian Cancer Cells by Enriching RAN and HSBP1 mRNA and Up-regulating its Protein Expression.

Authors:  Yancheng Zhong; Lanqin Cao; Haotian Ma; Qian Wang; Pingpin Wei; Juan Yang; Yuqing Mo; Lihua Cao; Cijun Shuai; Shuping Peng
Journal:  Int J Biol Sci       Date:  2020-04-15       Impact factor: 6.580

10.  The association of RAN and RANBP2 gene polymerphisms with Wilms tumor risk in Chinese children.

Authors:  Xiaokai Huang; Jie Zhao; Wen Fu; Jinhong Zhu; Susu Lou; Xiaoqian Tian; Shanshan Chen; Jichen Ruan; Jing He; Haixia Zhou
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.